Perhaps you think it's impossible to score another 1,000% gain off this "tech titan" stock. Think again. An unusual strategy lets you virtually "recreate" gains off the biggest companies you thought had come and gone. CLICK HERE to see how it works.
A company that many of our editors have been keeping track of over the past several weeks for its stock price as much for it’s borrowing of our Oxford Club’s Chairman’s Circle ideas is TheStreet.com (Nasdaq: TSCM).
And its recent price movements have been drawing a lot of interest from technical traders and fundamentalists as well. If you’re unfamiliar with TheStreet you’re probably familiar, if not aware of it’s outspoken leader Jim Cramer.
While many have questioned his entertainment factor against the value he’s added picking stocks for viewers, his real impact on TheStreet’s bottom line is immense. His face is a majority of the brand. The concern for investors would be for something to happen to him.
TheStreet publishes almost 100 new articles a day and uses the traffic to fuel its premium services and gain “eyeball” traffic that they can sell text and picture ads around.
Because we know how profitable a business segment and industry TheStreet is located in; (privately owned Investment U is as well) and without other publicly traded competitors to really give you an idea on the business model these companies use, we believe few understand the real value of this company and how under-priced this stock is.
Symbols mentioned in this article: TSCM
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed